Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-α

Recently, it was shown that interferon consensus sequence binding protein (ICSBP), a member of the interferon regulatory factor (IRF) family, has a potential role in chronic myeloid leukemia (CML). Deletion of ICSBP gene in mice leads to a CML-like syndrome and samples from CML patients exhibited im...

Full description

Saved in:
Bibliographic Details
Main Authors: Schmidt, Manuel (Author) , Hochhaus, Andreas (Author) , Nitsche, Andreas (Author) , Hehlmann, Rüdiger (Author) , Neubauer, Andreas (Author)
Format: Article (Journal)
Language:English
Published: June 1, 2001
In: Blood
Year: 2001, Volume: 97, Issue: 11, Pages: 3648-3650
ISSN:1528-0020
DOI:10.1182/blood.V97.11.3648
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood.V97.11.3648
Get full text
Author Notes:Manuel Schmidt, Andreas Hochhaus, Andreas Nitsche, Rüdiger Hehlmann, and Andreas Neubauer

MARC

LEADER 00000caa a2200000 c 4500
001 1802477896
003 DE-627
005 20220820184250.0
007 cr uuu---uuuuu
008 220518s2001 xx |||||o 00| ||eng c
024 7 |a 10.1182/blood.V97.11.3648  |2 doi 
035 |a (DE-627)1802477896 
035 |a (DE-599)KXP1802477896 
035 |a (OCoLC)1341460228 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schmidt, Manuel  |e VerfasserIn  |0 (DE-588)1255324902  |0 (DE-627)1799541479  |4 aut 
245 1 0 |a Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-α  |c Manuel Schmidt, Andreas Hochhaus, Andreas Nitsche, Rüdiger Hehlmann, and Andreas Neubauer 
246 3 3 |a Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-alpha 
264 1 |c June 1, 2001 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 18.05.2022 
520 |a Recently, it was shown that interferon consensus sequence binding protein (ICSBP), a member of the interferon regulatory factor (IRF) family, has a potential role in chronic myeloid leukemia (CML). Deletion of ICSBP gene in mice leads to a CML-like syndrome and samples from CML patients exhibited impaired ICSBP expression. The present study found that ICSBP expression correlated with risk features determined by Sokal score in untreated CML (P = .007 for high versus low risk). In addition, analyzing ICSBP expression during interferon-α (IFN-α) therapy in “good” (n = 27) versus “poor” (n = 15) cytogenetic responders, high ICSBP levels were only observed in “good” responders (P = .0002). Together, these data suggest that ICSBP levels are related to initial presentation of CML and the therapeutic response of CML to IFN-α, indicating an important role of ICSBP in CML. 
700 1 |a Hochhaus, Andreas  |d 1959-  |e VerfasserIn  |0 (DE-588)1107039339  |0 (DE-627)863321976  |0 (DE-576)474976130  |4 aut 
700 1 |a Nitsche, Andreas  |e VerfasserIn  |4 aut 
700 1 |a Hehlmann, Rüdiger  |d 1941-  |e VerfasserIn  |0 (DE-588)1037003489  |0 (DE-627)751737879  |0 (DE-576)390939463  |4 aut 
700 1 |a Neubauer, Andreas  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Blood  |d Washington, DC : American Society of Hematology, 1946  |g 97(2001), 11, Seite 3648-3650  |h Online-Ressource  |w (DE-627)266886647  |w (DE-600)1468538-3  |w (DE-576)075961938  |x 1528-0020  |7 nnas  |a Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-α 
773 1 8 |g volume:97  |g year:2001  |g number:11  |g pages:3648-3650  |g extent:3  |a Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-α 
856 4 0 |u https://doi.org/10.1182/blood.V97.11.3648  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220518 
993 |a Article 
994 |a 2001 
998 |g 1037003489  |a Hehlmann, Rüdiger  |m 1037003489:Hehlmann, Rüdiger  |d 60000  |d 61200  |e 60000PH1037003489  |e 61200PH1037003489  |k 0/60000/  |k 1/60000/61200/  |p 4 
998 |g 1107039339  |a Hochhaus, Andreas  |m 1107039339:Hochhaus, Andreas  |d 60000  |d 61200  |e 60000PH1107039339  |e 61200PH1107039339  |k 0/60000/  |k 1/60000/61200/  |p 2 
999 |a KXP-PPN1802477896  |e 4135881262 
BIB |a Y 
SER |a journal 
JSO |a {"titleAlt":[{"title":"Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-alpha"}],"language":["eng"],"person":[{"family":"Schmidt","display":"Schmidt, Manuel","given":"Manuel","role":"aut"},{"given":"Andreas","role":"aut","display":"Hochhaus, Andreas","family":"Hochhaus"},{"display":"Nitsche, Andreas","family":"Nitsche","given":"Andreas","role":"aut"},{"display":"Hehlmann, Rüdiger","family":"Hehlmann","given":"Rüdiger","role":"aut"},{"given":"Andreas","role":"aut","family":"Neubauer","display":"Neubauer, Andreas"}],"id":{"doi":["10.1182/blood.V97.11.3648"],"eki":["1802477896"]},"name":{"displayForm":["Manuel Schmidt, Andreas Hochhaus, Andreas Nitsche, Rüdiger Hehlmann, and Andreas Neubauer"]},"physDesc":[{"extent":"3 S."}],"relHost":[{"corporate":[{"display":"American Society of Hematology","role":"isb"}],"part":{"pages":"3648-3650","year":"2001","issue":"11","text":"97(2001), 11, Seite 3648-3650","volume":"97","extent":"3"},"titleAlt":[{"title":"Blood online"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-αBlood","title":[{"title":"Blood","title_sort":"Blood","subtitle":"journal of the American Society of Hematology"}],"origin":[{"publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif.","dateIssuedDisp":"1946-","publisher":"American Society of Hematology ; Saunders ; HighWire Press","dateIssuedKey":"1946"}],"pubHistory":["1.1946 -"],"note":["Gesehen am 21.04.2023"],"id":{"issn":["1528-0020"],"zdb":["1468538-3"],"eki":["266886647"]},"recId":"266886647","physDesc":[{"extent":"Online-Ressource"}]}],"recId":"1802477896","type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 18.05.2022"],"origin":[{"dateIssuedKey":"2001","dateIssuedDisp":"June 1, 2001"}],"title":[{"title_sort":"Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-α","title":"Expression of nuclear transcription factor interferon consensus sequence binding protein in chronic myeloid leukemia correlates with pretreatment risk features and cytogenetic response to interferon-α"}]} 
SRT |a SCHMIDTMANEXPRESSION1200